A new book argues that the arts have a role to play in shaking up the status quo in the American health care system and creating 'desperately needed culture change.'
Credit rating agencies have removed small unpaid medical bills from consumer credit, and some people are seeing their credit scores improve, a new study finds.
Laura Bray couldn't watch her 9-year-old's leukemia go untreated. She started campaigning to fix a broken system and get patients the treatments they need in the face of drug shortages.
Medicare's annual open enrollment period began Oct. 15, allowing seniors to choose new plans. New rules this year are supposed to crack down on misleading marketing but buyers should still beware.
Narcan is now available in drug stores without a prescription. The nasal spray can save a life by stopping an opioid overdose. But will people pay the price and ask for it by name?
In recent research AI has done a credible job at diagnosing health complaints. But should consumers trust unregulated bots with their health care? Doctors see trouble brewing.
The suits pursued patients and their families, sometimes putting liens on homes. "I know my house will never be mine. It is going to be the hospital's," said Donna Lindabury, 70, who lost her case.
The shift to electronic medical payments gave rise to a new kind of health care middlemen, who now charge 1-5% every time insurers pay doctors. Here's how lobbyists convinced regulators this was OK.
The Biden administration wants hospitals to do more to make their prices understandable, so that consumers know in advance what a health care service will cost them.
A term coined to evoke the torment felt by soldiers as they process the cruelty of war, it's now used by doctors to describe the guilt and helplessness we feel when patients can't access needed care.
A tornado that ripped through a Pfizer plant in Rocky Mount, N.C., raised worries about shortages of medicines used in hospitals. The drugs include commonly used painkillers and anesthetics.
Virtual access to doctors is a huge plus for patients. But it's a lot of new work for physicians. And the health care business model hasn't caught up with this new reality.
After years of being the world's best-selling drug, Humira faces competition from copycat versions known as biosimilars. One called Yusimry costs a $1,000 or less.
At least nine bills introduced in Congress take aim at pharmacy benefit managers, the powerful middlemen that channel prescription drugs to patients. Here's what the fuss is all about.
